4-iodoamphetamine has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwamiya, T; Kodama, F; Ohta, Y; Suto, Y | 1 |
| Fujiyama, S; Izuno, K; Sato, T; Shibata, J; Shimomura, O; Takahashi, M; Yoshida, K | 1 |
2 other study(ies) available for 4-iodoamphetamine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Increased uptake of I-123 IMP in peritoneal metastases of hepatocellular carcinoma.
Topics: Amphetamines; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Radionuclide Imaging | 1996 |
Transrectal portal scintigraphy with I123 iodoamphetamine in liver diseases.
Topics: Amphetamines; Carcinoma, Hepatocellular; Chronic Disease; Hepatitis; Humans; Iodine Radioisotopes; Liver Circulation; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Neoplasms; Radionuclide Imaging; Rectum | 1991 |